SG Americas Securities LLC lessened its holdings in The Allstate Corporation (NYSE:ALL – Free Report) by 2.7% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,481 shares of the insurance provider’s stock after selling 480 shares during the period. SG Americas Securities LLC’s holdings in Allstate were worth $3,519,000 at the end of the most recent reporting period.
Other hedge funds have also modified their holdings of the company. Parkside Financial Bank & Trust lifted its stake in Allstate by 4.7% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,189 shares of the insurance provider’s stock valued at $239,000 after buying an additional 53 shares in the last quarter. Linscomb Wealth Inc. raised its holdings in shares of Allstate by 1.3% in the first quarter. Linscomb Wealth Inc. now owns 4,079 shares of the insurance provider’s stock worth $845,000 after acquiring an additional 54 shares during the last quarter. Ancora Advisors LLC raised its holdings in shares of Allstate by 0.7% in the first quarter. Ancora Advisors LLC now owns 8,402 shares of the insurance provider’s stock worth $1,740,000 after acquiring an additional 55 shares during the last quarter. Cooper Financial Group lifted its position in shares of Allstate by 5.5% in the second quarter. Cooper Financial Group now owns 1,057 shares of the insurance provider’s stock valued at $213,000 after acquiring an additional 55 shares in the last quarter. Finally, D Orazio & Associates Inc. boosted its stake in shares of Allstate by 5.2% during the second quarter. D Orazio & Associates Inc. now owns 1,115 shares of the insurance provider’s stock valued at $224,000 after acquiring an additional 55 shares during the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on ALL shares. Evercore ISI set a $233.00 target price on shares of Allstate and gave the company an “in-line” rating in a research note on Wednesday, October 1st. Keefe, Bruyette & Woods lifted their price target on shares of Allstate from $246.00 to $250.00 and gave the stock an “outperform” rating in a report on Tuesday, November 11th. Jefferies Financial Group upped their price objective on shares of Allstate from $254.00 to $255.00 and gave the company a “buy” rating in a research note on Monday, August 11th. Morgan Stanley lifted their target price on shares of Allstate from $235.00 to $245.00 and gave the stock an “overweight” rating in a research note on Friday, August 1st. Finally, Roth Capital set a $230.00 price target on Allstate and gave the company a “buy” rating in a report on Friday, September 26th. Two research analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $237.64.
Insider Transactions at Allstate
In other Allstate news, insider Suren Gupta sold 400 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $215.22, for a total transaction of $86,088.00. Following the completion of the sale, the insider owned 100,646 shares of the company’s stock, valued at approximately $21,661,032.12. The trade was a 0.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.70% of the company’s stock.
Allstate Price Performance
Allstate stock opened at $210.15 on Wednesday. The Allstate Corporation has a 1 year low of $176.00 and a 1 year high of $215.70. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43. The firm has a 50 day moving average price of $202.72 and a 200 day moving average price of $201.85. The company has a market cap of $54.99 billion, a price-to-earnings ratio of 9.88, a PEG ratio of 0.69 and a beta of 0.35.
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share for the quarter, beating analysts’ consensus estimates of $5.48 by $5.69. The company had revenue of $17.26 billion for the quarter, compared to analyst estimates of $16.59 billion. Allstate had a net margin of 8.79% and a return on equity of 28.74%. Allstate’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter last year, the business earned $3.91 EPS. Sell-side analysts predict that The Allstate Corporation will post 18.74 earnings per share for the current year.
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- With Risk Tolerance, One Size Does Not Fit All
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- Basic Materials Stocks Investing
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
